Tentt

Samsung Biologics Completes Rockville Facility Buy

Closed
HealthcareMarylandDivestiture

Deal Overview

Samsung Biologics has completed its acquisition of GSK’s manufacturing facility in Rockville, Maryland. The closed transaction expands Samsung Biologics’ operations into the United States.

The excerpt provided does not include deal value or specific financial terms, but the acquired asset is a biologics manufacturing site in Rockville, supporting Samsung Biologics’ production footprint in the US.

Key Details

Transaction
Samsung Biologics acquires GSK manufacturing facility

Filed under

Source

Read full article on prnewswire.com

via GN - completed acquisition of · April 2, 2026

Powered by Tentt

Source healthcare deals in Maryland for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →See all deals in Maryland →